Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989;36(1):39-46.
doi: 10.1007/BF00561021.

Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man

Affiliations

Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man

E E Ohnhaus et al. Eur J Clin Pharmacol. 1989.

Abstract

The effect of enzyme induction by antipyrine, phenobarbitone and rifampicin on the time-course of urinary 6 beta-hydroxycortisol (6 beta-OHC) excretion was investigated in healthy volunteers. The drugs were given chronically for either seven or 14 days. Significant increases in 6 beta-OHC excretion were observed after 4 days administration of antipyrine (1.2 g), 13 days administration of phenobarbitone (100 mg), and only 2 days administration of rifampicin (0.6 or 1.2 g). During 14 days rifampicin administration (1.2 g) 6 beta-OHC excretion, for individual subjects, reached a maximum on Days 11-14 when excretion was significantly greater than on day 7. On stopping rifampicin, in a 7-day study, excretion decreased over the next six days, but still remained significantly elevated compared to the original control values. These studies show that measurement of urinary 6 beta-hydroxycortisol provides a simple non-invasive method with which to monitor the time-course of enzyme induction by drugs in man. However, the method cannot be used to predict clinically important drug interactions until the cytochrome P-450 enzyme responsible for cortisol 6 beta-hydroxylation has been fully characterized.

PubMed Disclaimer

References

    1. Clin Pharmacol Ther. 1984 Jan;35(1):1-11 - PubMed
    1. Metabolism. 1978 Aug;27(8):1003-11 - PubMed
    1. Clin Pharmacokinet. 1983 Sep-Oct;8(5):371-7 - PubMed
    1. Br J Clin Pharmacol. 1984 Sep;18(3):411-9 - PubMed
    1. Mol Pharmacol. 1965 Sep;1(2):149-56 - PubMed

LinkOut - more resources